
Thursday, May 12, 2022 10:53:24 PM
“The real wildcard here is just how much does BioNTech want to control the field of messenger RNA, and I think there’s obviously a great deal of value associated with something like that and a truly exclusive relationships, giving a multitude of areas that you can take messenger RNA vaccines, so that remains to be seen. Very encouraged by the spirit of discussions which really began at the highest levels between Ugur and myself quite a while ago. That spirit has continued and we’re working to sort of finalize that, no update on timing, and we won’t be commenting on it more broadly other than on today’s call.” (Jabbour)

Liked By
Spread the love. Be the first to like this post!
Recent MTNB News
- Matinas BioPharma Reports 2022 Financial Results and Provides a Business Update • GlobeNewswire Inc. • 03/15/2023 08:05:00 PM
- Matinas BioPharma to Webcast Conference Call to Discuss 2022 Financial Results and Provide a Business Update on March 15, 2023 • GlobeNewswire Inc. • 03/08/2023 12:00:00 PM
- Matinas BioPharma Announces that MAT2203 Will Be Featured in Two Oral Presentations at ECCMID • GlobeNewswire Inc. • 03/02/2023 12:00:00 PM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 01/30/2023 09:01:51 PM
- Matinas BioPharma Provides Business Update and 2023 Strategic Outlook • GlobeNewswire Inc. • 01/30/2023 09:01:00 PM
- Matinas BioPharma to Provide Corporate Update and 2023 Business Outlook on January 30, 2023 • GlobeNewswire Inc. • 01/23/2023 12:00:00 PM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 01/12/2023 12:00:42 PM
- Matinas BioPharma Announces Collaboration with National Resilience to Explore and Evaluate Novel LNC Platform Delivery Technology for Certain Nucleic Acids • GlobeNewswire Inc. • 01/12/2023 12:00:00 PM
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 12/22/2022 04:25:46 PM
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 12/22/2022 04:24:31 PM
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 12/22/2022 04:22:56 PM
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 12/22/2022 04:20:32 PM
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 12/22/2022 04:19:02 PM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 11/14/2022 10:44:02 PM
- Quarterly Report (10-q) • Edgar (US Regulatory) • 11/02/2022 08:03:18 PM
- Matinas BioPharma Reports Third Quarter 2022 Financial Results and Highlights Recent Progress • GlobeNewswire Inc. • 11/02/2022 08:02:00 PM
- Matinas BioPharma to Webcast Conference Call Discussing Third Quarter 2022 Operational and Financial Results on November 2, 2022 • GlobeNewswire Inc. • 10/27/2022 11:00:00 AM
- Matinas BioPharma Announces Positive Interim Data from the Phase 2 EnACT Trial of MAT2203 for the Treatment of Cryptococcal Meningitis, Exceeding Primary Endpoint Threshold; Patient Survival in All-Oral Cohort 4 Regimen Currently 90% • GlobeNewswire Inc. • 10/21/2022 11:48:01 AM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 10/21/2022 11:02:06 AM
- Matinas BioPharma to Present at the ThinkEquity Annual Global Investment Conference • GlobeNewswire Inc. • 10/21/2022 11:00:00 AM
- Matinas BioPharma Announces Infectious Diseases Society of America (IDSA) has Selected the EnACT Phase 2 Trial Abstract of MAT2203 as its Outstanding Abstract and IDSA Awardee For IDWeek 2022 • GlobeNewswire Inc. • 10/19/2022 11:10:00 AM
- Matinas BioPharma to Present New MAT2203 (Oral Amphotericin B) Data During IDWeek 2022 • GlobeNewswire Inc. • 10/12/2022 11:00:00 AM
- Proxy Statement (definitive) (def 14a) • Edgar (US Regulatory) • 09/22/2022 09:02:26 PM
- Matinas BioPharma Announces Chairman Succession Plan • GlobeNewswire Inc. • 09/21/2022 11:00:00 AM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 09/13/2022 11:01:55 AM
FEATURED Fineqia's EEA Unit Receives Approval of Base Prospectus for Issuing Exchange Traded Notes (ETNs) • Mar 28, 2023 9:37 AM
FEATURED Usha Resources Enters Hard-Rock Lithium Space with Acquisition of Significant Ontario Land Package with Highly Evolved LCT-Pegmatites • Mar 28, 2023 8:26 AM
FEATURED Edison Lithium Provides Update on Spin-Out of Cobalt Assets • Mar 28, 2023 8:09 AM
FEATURED Epazz Holdings: ZenaDrone, Inc. 1000 AI Predictive Received a Letter of Support from the US Airforce for Drone Cargo Delivery and Intent to Use ZenaDrone 1000 Platform • Mar 28, 2023 7:11 AM
Metatron Releases All-in-One Artificial Intelligence Mobile Apps for iPhone and Android • MRNJ • Mar 27, 2023 9:00 AM
Memorandum of Understanding With Miranda Water Treatment Systems and Rainmaker Worldwide Inc. Extended • RAKR • Mar 27, 2023 8:50 AM